Meta-analyses revealed altered BDNF levels in neurologic disorders, including Parkinson’s disease, Alzheimer’s disease, and psychiatric disorders, including autism, depression, post-traumatic stress disorder, and anxiety disorder, compared with normal controls [6,8,39–42]. The gene discussed is BDNF; the disease is depressive symptom measurement.